Clinical Trials on Cardiac Imaging in Japan

Total 151 results

Bayer

Completed

Magnevist Post-marketing Surveillance in Japan

Diagnostic Imaging

Japan
Bayer

Completed

Primovist Post-marketing Surveillance in Japan (PRIMOVIST)

Diagnostic Imaging

Japan
Nihon University

Completed

MR Images Variation With or Without Denture Wear

Magnetic Resonance Imaging

Japan
Bayer

Completed

Drug Use Investigation of Gadovist.

Magnetic Resonance Imaging | Image Enhancement

Japan
Bayer

Completed

A Study to Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants

Healthy Volunteers | Contrast Enhancement in Magnetic Resonance Imaging

Japan
Kurume University

Unknown

Pioglitazone Decreases Visceral Fat Metabolism

To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging

Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
Bayer

Completed

Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging

Magnetic Resonance Imaging

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Lead Extraction Registry (J-LEX)

Arrhythmia, Cardiac

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Catheter Ablation Registry (J-AB)

Cardiac Arrhythmias | Catheter Ablation

Japan
Bayer

Completed

Gadobutrol Magnevist-controlled Body Study

Magnetic Resonance Imaging

China, Korea, Republic of, Japan
Toujinkai Hospital

Completed

Circulating P3NP and Cardiovascular Events in Hemodialysis Patients

Cardiac Fibrosis | Cardiovascular Events

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Nagano Children's Hospital

Recruiting

Effects of Parents Included in Medical Round of Neonatal Intensive Care Unit

Decision Making | Family Centered Care

Japan
Kobe University
Mochida Pharmaceutical Company, Ltd.

Completed

Protective Effect of EPA on Cardiovascular Events

Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease

Japan
Daiichi Sankyo Co., Ltd.

Completed

Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Japan
Kyoto University, Graduate School of Medicine

Completed

Kansai Plus Atrial Fibrillation Trial (KPAF)

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Japanese Pradaxa PMS, Long Term

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

Atrial Fibrillation

Japan
Nagoya University

Unknown

Investigation of Genetic Risk of Atrial Fibrillation

Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Non-valvular Atrial Fibrillation

Japan
Biotronik Japan, Inc.

Completed

Safety and Efficacy Study of IPG Patient With Home Monitoring

Bradyarrhythmia

Japan
Pfizer

Completed

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (CER3)

Non-valvular Atrial Fibrillation

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Atrial Fibrillation

Japan
Japan Cardiovascular Research Foundation

Unknown

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (GENeRAL)

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Non-Valvular Atrial Fibrillation (NVAF)

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Arrhythmia

Japan
Boehringer Ingelheim

Completed

Medical Need of OAC Reversal

Atrial Fibrillation

Japan
Bristol-Myers Squibb
Pfizer

Completed

Evaluation of Safety and Effectiveness on Oral Anticoagulants (RCR-OAC)

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate

Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Non-valvular Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Non-valvular Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Kumamoto University

Completed

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

Coronary Artery Disease | Cardiac CT

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

Cardiac Edema

Japan
University of Arizona

Completed

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD)

Ventricular Tachycardia (VT)

Japan, Taiwan, China, United States, Korea, Republic of
Interleukin Genetics, Inc.

Completed

Identification of Gene Biomarkers in Aging Skin

Hyperpigmentation | Skin Aging

Japan
Ministry of Health, Labour and Welfare, Japan

Completed

Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery

Coronary Disease | Atrial Fibrillation

Japan
Nara Medical University

Unknown

Hemofiltration for Contrast-Induced Nephropathy

Chronic Kidney Disease | Cardiac Catheterization

Japan
Bristol-Myers Squibb
Pfizer

Completed

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NonValvular Atrial Fibrillation

Japan
Bayer

Active, not recruiting

An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

Liver Metastases | Metastatic Pancreatic Cancer | Gadoxetate Sodium-enhanced Magnetic Resonance Imaging

Japan
Satoshi Shizuta
Daiichi Sankyo Co., Ltd.; Research Institute for Production Development

Completed

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (OAC-ALONE)

Coronary Artery Disease | Atrial Fibrillation

Japan
Bayer

Completed

Bioequivalence Study of Rivaroxaban

Embolism, Atrial Fibrillation and Venous Thrombosis

Japan
Bayer

Completed

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

Embolism, Atrial Fibrillation and Venous Thrombosis

Japan
Institute for Clinical Effectiveness, Japan

Recruiting

Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial (LEAP-AF)

Persistent Atrial Fibrillation | Catheter Ablation | Pulmonary Vein Isolation | Posterior Wall Isolation

Japan
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Non-valvular Atrial Fibrillation

Japan
Novo Nordisk A/S

Completed

Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

Healthy | Acquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary Bypass

Japan
Toujinkai Hospital

Completed

Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients

Congestive Heart Failure | Acute Myocardial Infarction

Japan

3

Subscribe